BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock Holdings Boosted by Brown Lisle Cummings Inc.

Brown Lisle Cummings Inc. increased its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 17.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,711 shares of the company’s stock after buying an additional 6,198 shares during the quarter. Brown Lisle Cummings Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $615,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Penserra Capital Management LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the 3rd quarter worth $15,390,000. Absolute Investment Advisers LLC purchased a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth about $3,941,000. Sanctuary Advisors LLC purchased a new position in BlackRock Health Sciences Term Trust in the 2nd quarter worth about $3,179,000. Kingswood Wealth Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust during the 4th quarter worth about $420,000. Finally, Jane Street Group LLC purchased a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at about $357,000.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at $16.38 on Tuesday. BlackRock Health Sciences Term Trust has a fifty-two week low of $14.27 and a fifty-two week high of $16.75. The firm’s 50 day simple moving average is $15.44 and its 200-day simple moving average is $15.64.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which was paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th were given a dividend of $0.1782 per share. This represents a $2.14 annualized dividend and a yield of 13.05%. The ex-dividend date was Wednesday, January 15th.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.